Mirum Pharmaceuticals
MIRM
39 hedge funds and large institutions have $398M invested in Mirum Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 9 closing their positions.
140% more capital invested
Capital invested by funds: $166M → $398M (+$233M)
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
0% more funds holding
Funds holding: 39 → 39 (0)
1.04% less ownership
Funds ownership: 71.72% → 70.68% (-1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$4.85M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$3.38M |
| 3 |
BlackRock
New York
|
+$1.56M |
| 4 |
O
OrbiMed
New York
|
+$760K |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$645K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$11.5M |
| 2 |
Millennium Management
New York
|
-$1.1M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$513K |
| 4 |
DIM
DC Investments Management
Mclean,
Virginia
|
-$457K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$313K |
MIRM Hedge Fund Activity: Q4 2019 in Review
39 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2019, worth a combined $398M — up 140% from $166M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new MIRM positions and 9 closed out — a net gain of 5 holders — while 12 added to existing stakes and 7 trimmed.
The largest buyer was Rock Springs Capital Management, adding an estimated $4.85M. The largest seller was AllianceBernstein, exiting entirely with an estimated $11.5M sold.
- 39 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $398M of Mirum Pharmaceuticals stock for Q4 2019, up 140% quarter-over-quarter.
- 14 funds opened new Mirum Pharmaceuticals positions in Q4 2019 and 9 closed out, a net change of +5 holders.
- The largest Mirum Pharmaceuticals buyer in Q4 2019 was Rock Springs Capital Management, an estimated $4.85M added.
- The largest Mirum Pharmaceuticals seller in Q4 2019 was AllianceBernstein, an estimated $11.5M sold.
Based on aggregated 13F filings for Q4 2019.